经导管主动脉瓣植入术后左束支区域起搏的初步临床经验
本研究为单中心回顾性研究,纳入35例TAVI术后置入永久起搏器的患者,比较左束支区域起搏(LBBP,12例)与右心室心尖部起搏(RVAP,23例)的疗效与安全性。结果显示LBBP手术成功率为11/12,无严重并发症,术后3、6个月左心室射血分数更高、NT-proBNP更低,QRS时限更短,但手术时间和X线透视时间更长。
要点
- TAVI术后需永久起搏的患者中,LBBP手术成功率为11/12,无严重手术相关并发症。
- LBBP组术后3、6个月左心室射血分数高于RVAP组,NT-proBNP低于RVAP组。
- LBBP组术后1、3、6个月QRS时限均短于RVAP组,但手术时间和X线透视时间更长。
核心结论
- 对于TAVI术后存在永久起搏器适应证的患者,LBBP是可行、安全可靠的,短期可改善心功能状态,远期效果尚待进一步观察。
研究设计与样本
- 本研究为回顾性研究,连续入选2018年1月至2020年12月在北京阜外医院接受TAVI治疗、术后置入永久起搏器的患者35例。
- 根据心室电极放置位置分为LBBP组(12例)和RVAP组(23例),比较两组手术参数、起搏器程控参数及临床指标。
主要发现
- LBBP组手术时间(86.58±17.10)min长于RVAP组(68.74±9.18)min,P<0.001;X线透视时间(20.08±4.44)min长于RVAP组(17.00±2.26)min,P<0.001。
- LBBP组手术成功率为11/12,无气胸、血胸、电极脱位、感染及囊袋出血等严重手术相关并发症。
- 术后3个月LBBP组左心室射血分数(60.75±2.89)%高于RVAP组(57.35±3.33)%,P=0.004;术后6个月(63.17±3.33)%高于(56.17±3.97)%,P<0.001。
- 术后3个月LBBP组NT-proBNP 822(607,1 150)ng/L低于RVAP组1 052(902,1 536)ng/L,P=0.006;术后6个月440(330,679)ng/L低于783(588,1 023)ng/L,P=0.001。
- 术后1、3、6个月LBBP组QRS时限均短于RVAP组(1个月:99(97,107)ms比126(124,130)ms;3个月:98(96,105)ms比129(128,133)ms;6个月:96(94,104)ms比130(128,132)ms,P均<0.001)。
临床怎么用
- 对于TAVI术后存在永久起搏器适应证的患者,可考虑选择LBBP以改善短期心功能并缩小QRS时限。
- LBBP手术时间和X线透视时间较长,操作中需注意技术熟练度与辐射暴露管理。
局限性
- 本研究为单中心回顾性研究,样本量较小(共35例),随访时间较短(7.43(5.21,9.84)个月),远期疗效尚待进一步观察。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Objective: To investigate the efficacy and safety of left bundle branch pacing(LBBP) in patients after transcatheter aortic valve implantation (TAVI). Methods: This is a retrospective study. A total of 35 patients underwent TAVI and received pacemaker implantation from January 2018 to December 2020 in Beijing Fuwai Hospital were enrolled. Patients were divided into LBBP group (n=12) and right ventricular apex pacing (RVAP) group (n=23) according to the pacing position. The success rate of operation in LBBP group was calculated, and the occurrence of complications were observed, and the parameters of pacemaker were measured on the 3rd day and 1, 3 and 6 months after operation. The N-terminal pro-B-type natriuretic peptide (NT-proBNP), echocardiographic and ECG indexes were compared between the two groups on the 3rd day and 1, 3, and 6 months after pacemaker implantation. Result: A total of 35 patients were included, The age was (76.4±7.7) years, including 19 males (54.3%). The procedure time ((86.58±17.10)min vs. (68.74±9.18)min, P<0.001) and fluoroscopy duration ((20.08±4.44)min vs. (17.00±2.26)min, P<0.001) were significantly longer in LBBP group compared with RVAP group. The operation success rate of LBBP group was 11/12. There was no serious operation related complications such as pneumothorax, hemothorax, electrode dislocation, infection, and lower limb bleeding. The patients were followed up for 7.43 (5.21, 9.84) months. The programmed parameters of pacemaker were in the ideal range and stable during follow-up. At 3 and 6 months after operation, the left ventricular ejection fraction in LBBP group was higher than that in RVAP Group (at 3 months: (60.75±2.89)% vs. (57.35±3.33)%, P=0.004; at 6 months: (63.17±3.33)% vs. (56.17±3.97)%, P<0.001), NT-proBNP values was lower in LBBP group than that in RVAP Group (at 3 months: 822 (607, 1 150)ng/L vs. 1 052 (902, 1 536)ng/L, P=0.006; at 6 months: 440 (330,679)ng/L vs. 783 (588, 1 023)ng/L, P=0.001). At 1, 3 and 6 months after operation, the QRS duration was shorter in LBBP group than that in RVAP group (1 month: 99 (97, 107)ms vs. 126(124, 130)ms, P<0.001; 3 months: 98(96, 105)ms vs. 129(128, 133)ms, P<0.001; 6 months: 96(94, 104)ms vs. 130(128, 132)ms, P<0.001). Conclusions: For patients with permanent pacemaker indications after TAVI, LBBP is feasible, safe and reliable. It could improve the cardiac function in the short term, the long-term effect of LBBP needs to be further observed. 目的: 探讨左束支区域起搏(LBBP)运用于经导管主动脉瓣植入术(TAVI)后患者的可行性和安全性。 方法: 本研究为回顾性研究。连续入选2018年1月至2020年12月在中国医学院科学院阜外医院接受TAVI治疗、术后置入永久起搏器的患者35例。根据心室电极放置位置,分为LBBP组(12例)和右心室心尖部起搏(RVAP)组(23例)。计算LBBP组患者的手术成功率,观察其手术相关并发症发生情况,并于术后第3天及1、3、6个月测量起搏器程控参数。比较两组患者TAVI术后1、3、6个月时的N末端B型利钠肽原(NT-proBNP)及超声心动图、心电图指标。 结果: 共纳入35例患者,年龄(76.4±7.7)岁,男性19例(54.3%)。与RVAP组患者比较,LBBP组患者在起搏器置入术中的手术时间[(86.58±17.10)min比(68.74±9.18)min,P<0.001]及X线透视时间[(20.08±4.44)min比(17.00±2.26)min,P<0.001]更长。LBBP组患者的手术成功率为11/12,12例患者均无气胸和血胸、电极脱位、感染以及囊袋出血等严重手术相关并发症发生,随访期间起搏器程控参数均在理想范围且稳定。共随访7.43(5.21,9.84)个月,术后3、6个月时,与RVAP组患者比较,LBBP组患者的左心室射血分数值均更高[3个月时:(60.75±2.89)%比(57.35±3.33)%,P=0.004;6个月时:(63.17±3.33)%比(56.17±3.97)%,P<0.001],NT-proBNP值均更低[3个月:822(607,1 150)ng/L比1 052(902,1 536)ng/L,P=0.006;6个月:440(330,679)ng/L比783(588,1 023)ng/L,P=0.001];术后1、3、6个月时,LBBP组患者的QRS时限均较RVAP组患者短[1个月时:99(97,107)ms比126(124,130)ms,P<0.001;3个月时:98(96,105)ms比129(128,133)ms,P<0.001;6个月时:96(94,104)ms比130(128,132)ms,P<0.001]。 结论: 对于TAVI术后存在永久起搏器适应证的患者,LBBP是可行、安全可靠的,短期可改善患者的心功能状态,但远期效果尚待进一步观察。.
引用
- Feng TJ, Song GY, Zhao J, et al. [Initial clinical experience of left bundle branch pacing after transcatheter aortic valve implantation]. Zhonghua Xin Xue Guan Bing Za Zhi. 2022. PMID: 35172458. doi:10.3760/cma.j.cn112148-20211018-00896
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。